Lessons Learned from Past Prize Winners

A conversation with Song Kim ’20, co-founder of KovaDX, which is building technologically advanced tools to increase access to quality healthcare for underserved communities.

InnovateHealth Yale is accepting applications for its Rita Wilson Seed Grant in Support of Innovation and Entrepreneurship through Oct. 9.

Bader Khraibut, MD, MPH '23, an American-born Kuwaiti citizen, didn't plan on starting a company. But that's what he did. In December 2021, shortly after beginning pursuit of a master's degree in public health (health care management) at the Yale School of Public Health, he co-founded New Haven-based Prophema Applied Research, a contract research organization (CRO).

April Koh ’16 and Adam Checkroud GRD ’18 have created an entrepreneurial unicorn, or private company valued at above $1 billion, that aims to improve the delivery of mental healthcare services.

April Koh, YC ’16, recently became the youngest U.S. CEO of a so-called “unicorn” - a privately held startup company valued at over $1 billion.

During her undergraduate years at Yale University, April Koh learned firsthand how frustrating and expensive it can be to find effective help for mental health illnesses. Her best friend and roommate cycled through multiple doctors and medications for an eating disorder, and ultimately needed a leave of absence to secure treatment; Koh, meanwhile, was dealing with her own mental health issues and struggling to find the right course of treatment.

Yale Resident Ruchit Nagar Receives 3rd Prize in The Trinity Challenge

Research says that counterfeit medication is the cause of 1 million deaths per year. One-tenth of this number comes from Africa. Counterfeiting is hard to detect, investigate, quantify or stop. It is a global problem, with annual earnings from substandard drugs standing at over $100 billion.